Across TCGA pan-cancer cohorts, GDPGP1 Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated GDPGP1 data layer compared with 26 for mass-spec protein and 5 for mass-spec protein.

The strongest signal is observed in kidney chromophobe (KICH), where higher GDPGP1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated GDPGP1 expression acts as an unfavorable survival marker, although some lineages such as SKCM show a favorable association.

KICH, LUSC, and SKCM are the cancer types where GDPGP1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	OS	Median	All	0.161	0.881	<.001	24	view →
LUSC	DFS	Median	All	0.054	0.760	<.001	18	view →
SKCM	DFS	Median	II,III,IV	1.000	0.546	.027	4	view →
COAD	DFS	Median	All	0.174	0.568	.041	2	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: GDPGP1 tumor-vs-normal RNA expression · all GDPGP1 data types